ary pharmacology
Page 1 of3rd
1149https://online2pdf.com/remove-pdf-header-footer
ofedition
149https://online2pdf.com/remove-pdf-header-footer
by bruce j colbert test bank.pdfhttps://online2pdf.com/re
onary pharmacology
10/24/2026https://online2pdf.com/remove-pdf-header-footer
Page
3rd edition
1https://online2pdf.com/remove-pdf-header-footer
by bruce j colbert test bankhttps://online2pdf.com/rem
,Page 2 of 149https://online2pdf.com/remove-pdf-header-footer
Integrated cardiopulmonary pharmacology 3rd edition by bruce j colbert test bank.pdfhttps://online2pdf.com/remove-pdf-header-footer
2 of 149https://online2pdf.com/remove-pdf-header-footer
Colbert_icp3_TestBank_questions
Test Bank
Chapter 1
MULTIPLE CHOICE
Choose the one alternative that best completes the statement or answers the
question.
1. Which term best describes the study of drugs and their action on the
body?
a. Therapeutics
b. Pharmacology
c. Pharmacotherapy
d. Disease management
2. The most common source of drugs today is:
a. Plants.
b. Animals.
c. Chemical synthesis.
d. Genetic bioengineering.
3. The agency that regulates drug testing and approves new drugs is the:
a. Center for Drug Evaluation and Research (CDER).
b. Centers for Disease Control and Prevention (CDC).
c. National Institutes of Health (NIH).
d. Food and Drug Administration (FDA).
4. The phase of drug testing that is performed to look for rare or serious
adverse effects after the drug is marketed is:
a. Phase I.
b. Phase II.
c. Phase III.
Page 1 of 148
10/24/2026https://online2pdf.com/remove-pdf-header-footer
Integrated cardiopulmonary pharmacology 3rd edition by bruce j colbert test bankhttps://online2pdf.com/remove-pdf-header-footer
Page 2https://online2pdf.com/remove-pdf-header-footer
,Page 3 of 149https://online2pdf.com/remove-pdf-header-footer
Integrated cardiopulmonary pharmacology 3rd edition by bruce j colbert test bank.pdfhttps://online2pdf.com/remove-pdf-header-footer
3 of 149https://online2pdf.com/remove-pdf-header-footer
Colbert_icp3_TestBank_questions
d. Phase IV.
5. What organization is officially responsible for establishing public
standards that approved drugs must continue to meet?
a. The Physicians’ Desk Reference (PDR)
b. The American Hospital Formulary Service (AHFS)
c. The United States Pharmacopeia (USP)
d. The Food and Drug Administration (FDA)
6. The name given to a drug that is considered the nonproprietary name
and is not owned by any particular pharmaceutical company is the:
a. Chemical name.
b. Generic name.
c. Trade name.
d. Brand name.
.
7. A 21-year-old pregnant female has been exposed to the drug Virazole,
which has been reported to cause damage to the fetus. This type of drug
exposure is referred to as:
a. An adverse drug reaction (ADR).
b. A life-threatening reaction.
c. Hypersensitivity.
d. Teratogenicity.
8. Drugs that do not go directly into the systemic circulation after being
absorbed and are metabolized through the liver describes a:
a. Steady state.
b. First-pass effect.
c. Therapeutic range.
Page 2 of 148
10/24/2026https://online2pdf.com/remove-pdf-header-footer
Integrated cardiopulmonary pharmacology 3rd edition by bruce j colbert test bankhttps://online2pdf.com/remove-pdf-header-footer
Page 3https://online2pdf.com/remove-pdf-header-footer
, Page 4 of 149https://online2pdf.com/remove-pdf-header-footer
Integrated cardiopulmonary pharmacology 3rd edition by bruce j colbert test bank.pdfhttps://online2pdf.com/remove-pdf-header-footer
4 of 149https://online2pdf.com/remove-pdf-header-footer
Colbert_icp3_TestBank_questions
d. Half-life.
9. A physician would like a patient to receive acetaminophen via the
enteral route. Your choice of administration may include:
I. Oral.
II. Nasogastric.
III. Rectal.
a. I
b. I and II
c. I and III
d. I, II, and III
10. Administration of 80 mg propranolol given orally (PO) produces the
same response as 1 mg intravenously (IV). The difference in dosage is
explained by:
a. The first-pass effect.
b. Bioavailability.
c. Protein binding.
d. Metabolism.
11. The most common and convenient route of drug administration is:
a. Oral.
b. Inhalation.
c. Sublingual.
d. Transdermal.
12. A malnourished patient is susceptible to an increase in drug response
because of all except which of the following?
a. A malnourished patient has less serum albumin.
Page 3 of 148
10/24/2026https://online2pdf.com/remove-pdf-header-footer
Integrated cardiopulmonary pharmacology 3rd edition by bruce j colbert test bankhttps://online2pdf.com/remove-pdf-header-footer
Page 4https://online2pdf.com/remove-pdf-header-footer
Page 1 of3rd
1149https://online2pdf.com/remove-pdf-header-footer
ofedition
149https://online2pdf.com/remove-pdf-header-footer
by bruce j colbert test bank.pdfhttps://online2pdf.com/re
onary pharmacology
10/24/2026https://online2pdf.com/remove-pdf-header-footer
Page
3rd edition
1https://online2pdf.com/remove-pdf-header-footer
by bruce j colbert test bankhttps://online2pdf.com/rem
,Page 2 of 149https://online2pdf.com/remove-pdf-header-footer
Integrated cardiopulmonary pharmacology 3rd edition by bruce j colbert test bank.pdfhttps://online2pdf.com/remove-pdf-header-footer
2 of 149https://online2pdf.com/remove-pdf-header-footer
Colbert_icp3_TestBank_questions
Test Bank
Chapter 1
MULTIPLE CHOICE
Choose the one alternative that best completes the statement or answers the
question.
1. Which term best describes the study of drugs and their action on the
body?
a. Therapeutics
b. Pharmacology
c. Pharmacotherapy
d. Disease management
2. The most common source of drugs today is:
a. Plants.
b. Animals.
c. Chemical synthesis.
d. Genetic bioengineering.
3. The agency that regulates drug testing and approves new drugs is the:
a. Center for Drug Evaluation and Research (CDER).
b. Centers for Disease Control and Prevention (CDC).
c. National Institutes of Health (NIH).
d. Food and Drug Administration (FDA).
4. The phase of drug testing that is performed to look for rare or serious
adverse effects after the drug is marketed is:
a. Phase I.
b. Phase II.
c. Phase III.
Page 1 of 148
10/24/2026https://online2pdf.com/remove-pdf-header-footer
Integrated cardiopulmonary pharmacology 3rd edition by bruce j colbert test bankhttps://online2pdf.com/remove-pdf-header-footer
Page 2https://online2pdf.com/remove-pdf-header-footer
,Page 3 of 149https://online2pdf.com/remove-pdf-header-footer
Integrated cardiopulmonary pharmacology 3rd edition by bruce j colbert test bank.pdfhttps://online2pdf.com/remove-pdf-header-footer
3 of 149https://online2pdf.com/remove-pdf-header-footer
Colbert_icp3_TestBank_questions
d. Phase IV.
5. What organization is officially responsible for establishing public
standards that approved drugs must continue to meet?
a. The Physicians’ Desk Reference (PDR)
b. The American Hospital Formulary Service (AHFS)
c. The United States Pharmacopeia (USP)
d. The Food and Drug Administration (FDA)
6. The name given to a drug that is considered the nonproprietary name
and is not owned by any particular pharmaceutical company is the:
a. Chemical name.
b. Generic name.
c. Trade name.
d. Brand name.
.
7. A 21-year-old pregnant female has been exposed to the drug Virazole,
which has been reported to cause damage to the fetus. This type of drug
exposure is referred to as:
a. An adverse drug reaction (ADR).
b. A life-threatening reaction.
c. Hypersensitivity.
d. Teratogenicity.
8. Drugs that do not go directly into the systemic circulation after being
absorbed and are metabolized through the liver describes a:
a. Steady state.
b. First-pass effect.
c. Therapeutic range.
Page 2 of 148
10/24/2026https://online2pdf.com/remove-pdf-header-footer
Integrated cardiopulmonary pharmacology 3rd edition by bruce j colbert test bankhttps://online2pdf.com/remove-pdf-header-footer
Page 3https://online2pdf.com/remove-pdf-header-footer
, Page 4 of 149https://online2pdf.com/remove-pdf-header-footer
Integrated cardiopulmonary pharmacology 3rd edition by bruce j colbert test bank.pdfhttps://online2pdf.com/remove-pdf-header-footer
4 of 149https://online2pdf.com/remove-pdf-header-footer
Colbert_icp3_TestBank_questions
d. Half-life.
9. A physician would like a patient to receive acetaminophen via the
enteral route. Your choice of administration may include:
I. Oral.
II. Nasogastric.
III. Rectal.
a. I
b. I and II
c. I and III
d. I, II, and III
10. Administration of 80 mg propranolol given orally (PO) produces the
same response as 1 mg intravenously (IV). The difference in dosage is
explained by:
a. The first-pass effect.
b. Bioavailability.
c. Protein binding.
d. Metabolism.
11. The most common and convenient route of drug administration is:
a. Oral.
b. Inhalation.
c. Sublingual.
d. Transdermal.
12. A malnourished patient is susceptible to an increase in drug response
because of all except which of the following?
a. A malnourished patient has less serum albumin.
Page 3 of 148
10/24/2026https://online2pdf.com/remove-pdf-header-footer
Integrated cardiopulmonary pharmacology 3rd edition by bruce j colbert test bankhttps://online2pdf.com/remove-pdf-header-footer
Page 4https://online2pdf.com/remove-pdf-header-footer
